Bicalutamide Tablets

Pre-Solicitation Posted

Solicitation number
SPE2D2-26-R-0016
Agency
Responses due
Not on record
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Bicalutamide 50MG Tablets with a projected release date of October 2026. This is an unrestricted, fully competitive acquisition with no set-aside.

The contract will supply Bicalutamide 50MG Tablets in 30, 100, and 500 count bottles to the Department of War, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. Performance will support a national supply source in accordance with FAR 52.216-21 (Requirements).

The contract structure consists of a firm-fixed price, requirements-type vehicle with a one-year base period and four one-year options. Annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR Part 12.

The solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov. Interested parties should contact Christopher Newman at (445) 737-7371 or Christopher.Nemwan@dla.mil with questions. Parties are advised to set up automated notifications through Sam.Gov to track pre-solicitation and solicitation changes. DLA reserves the right to issue the solicitation before or after the October 2026 projected date.

Notice text

The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Bicalutamide Tablets. Procurement details follow.

Bicalutamide 50MG Tablets in 30, 100, and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of War (DoW), Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Christopher Newman at (445) 737-7371 or Christopher.Nemwan@dla.mil with any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is October 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside
Febuxostat Tablets NAICS 325412 Medical Supply Chain No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity